Skip to main content
SpringerLink
Log in

Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aim

The benefits of coffee on abnormal liver biochemistry, cirrhosis and hepatocellular carcinoma have been reported, but there is a lack of satisfactory explanation. Thus, this study aims to investigate if coffee use has any relationship with bright liver, measured by ultrasound bright liver score (BLS), in patients with non-alcoholic fatty liver disease (NAFLD), and which relationship, if any, is present with BMI and insulin resistance.

Methods

This study was performed on 245 patients, 137 with NAFLD and 108 controls. Coffee drinking was defined according to the absolute number of cups of coffee (only espresso coffee), and also graded as 1 (0 cups of coffee/day), 2 (1–2 cups of coffee/day) 3 (≥3 cups of coffee/day). Insulin resistance was assessed by homoeostasis model-insulin resistance index (HOMA).

Results

Less fatty liver involvement is present in coffee vs. non-coffee drinkers. Odds ratios show that obesity, higher insulin resistance, lower HDL cholesterol, older age and arterial hypertension are associated with a greater risk of more severe BLS; to the contrary, coffee drinking is associated with less severe BLS. In the multiple logistic regression (MLR) model, number of cups of coffee, HOMA and BMI account for 35.8% of the variance to BLS. Coffee use is inversely associated with the degree of bright liver, along with insulin resistance and obesity, which, to the contrary, are directly associated with greater likelihood and severity of bright liver appearance.

Conclusions

A possible opposite, if not antagonistic, role of coffee with regard to overweightness and insulin resistance, similar to that reported in hepatocarcinoma and cirrhosis, is envisaged in the natural history of NAFLD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology. 2008;48:129–136.

    Article  PubMed  Google Scholar 

  2. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007;132:1740–1745.

    Article  PubMed  Google Scholar 

  3. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006;166:1190–1195.

    Article  PubMed  Google Scholar 

  4. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003;13:419–423.

    Article  PubMed  Google Scholar 

  5. Corrao G, Zambon A, Bagnardi V, D’Amicis A, Klatsky A, Collaborative SIDECAR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001;11:458–465.

    Article  CAS  PubMed  Google Scholar 

  6. Nakanishi N, Nakamura K, Suzuki K, Tatara K. Lifestyle and the development of increased serum gamma-glutamyltransferase in middle-aged Japanese men. Scand J Clin Lab Invest. 2000;60:429–438.

    Article  CAS  PubMed  Google Scholar 

  7. Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord. 2002;2:11–19.

    PubMed  Google Scholar 

  8. Goessling W, Massaro JM, Vasan RS, D’Agostino RB Sr, Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135:1935–1944.

    Article  CAS  PubMed  Google Scholar 

  9. Mathiesen UL, Franzén LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516–522.

    Article  CAS  PubMed  Google Scholar 

  10. Ratziu V, Charlotte F, Heurtier A, LIDO Study Group, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898–1906.

    Article  PubMed  Google Scholar 

  11. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750.

    Article  PubMed  Google Scholar 

  12. Wilfred de Alwis NM, Day CP. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis. 2007;27:44–54.

    Article  PubMed  Google Scholar 

  13. Higashikawa A, Suwazono Y, Okubo Y, et al. Association of working conditions and lifestyle with increased serum gamma-glutamyltransferase: a follow-up study. Arch Med Res. 2005;36:567–573.

    Article  CAS  PubMed  Google Scholar 

  14. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992;136:1248–1257.

    CAS  PubMed  Google Scholar 

  15. Corrao G, Lepore AR, Torchio P, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial group for the study of chronic liver disease. Eur J Epidemiol. 1994;10:657–664.

    Article  CAS  PubMed  Google Scholar 

  16. McLean AE. Coffee, alcohol, and liver enzymes. Lancet. 1968;2:1035.

    Article  CAS  PubMed  Google Scholar 

  17. Catalano D, Trovato GM, Spadaro D, et al. Insulin resistance in postmenopausal women: concurrent effects of hormone replacement therapy and coffee. Climacteric. 2008;11:373–382.

    Article  CAS  PubMed  Google Scholar 

  18. Moisey LL, Kacker S, Bickerton AC, Robinson LE, Graham TE. Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr. 2008;87:1254–1261.

    CAS  PubMed  Google Scholar 

  19. Hino A, Adachi H, Enomoto M, et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract. 2007;76:383–389.

    Article  CAS  PubMed  Google Scholar 

  20. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005;128:24–32.

    Article  CAS  PubMed  Google Scholar 

  21. Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A. Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int. 2008;28:1280–1287.

    Article  CAS  PubMed  Google Scholar 

  22. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci. 2005;50:171–180.

    Article  PubMed  Google Scholar 

  23. Solga S, Alkhuraishe AR, Clark JM, et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004;49:1578–1583.

    Article  PubMed  Google Scholar 

  24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.

    Article  CAS  PubMed  Google Scholar 

  25. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 2002;40:1155–1163.

    Article  CAS  PubMed  Google Scholar 

  26. Aller R, de Luis DA, Fernandez L, et al. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig Dis Sci. 2008;53:1088–1092.

    Article  CAS  PubMed  Google Scholar 

  27. Hu KQ, Currie SL, Shen H, et al. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of US veterans. Dig Dis Sci. 2007;52:570–578.

    Article  PubMed  Google Scholar 

  28. Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes. 2001;50:2349–2354.

    Article  CAS  PubMed  Google Scholar 

  29. Arnlöv J, Vessby B, Risérus U. Coffee consumption and insulin sensitivity. JAMA. 2004;291:1199–1201.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica di Medicina Interna e Terapia Medica, Dipartimento di Medicina Interna, Facoltà di Medicina e Chirurgia, Università di Catania, Catania, Italy

    Daniela Catalano, Giuseppe Fabio Martines, Antonia Tonzuso, Clara Pirri, Francesca M. Trovato & Guglielmo M. Trovato

Authors
  1. Daniela Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Fabio Martines
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonia Tonzuso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Clara Pirri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesca M. Trovato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guglielmo M. Trovato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guglielmo M. Trovato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catalano, D., Martines, G.F., Tonzuso, A. et al. Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD). Dig Dis Sci 55, 3200–3206 (2010). https://doi.org/10.1007/s10620-010-1143-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1143-3

Keywords

Search

Navigation